GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Medical System Holdings Ltd (FRA:2M7C) » Definitions » EV-to-EBITDA

China Medical System Holdings (FRA:2M7C) EV-to-EBITDA : 4.05 (As of May. 05, 2024)


View and export this data going back to 2010. Start your Free Trial

What is China Medical System Holdings EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, China Medical System Holdings's enterprise value is €1,521 Mil. China Medical System Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €376 Mil. Therefore, China Medical System Holdings's EV-to-EBITDA for today is 4.05.

The historical rank and industry rank for China Medical System Holdings's EV-to-EBITDA or its related term are showing as below:

FRA:2M7C' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.46   Med: 12.26   Max: 37.38
Current: 3.96

During the past 13 years, the highest EV-to-EBITDA of China Medical System Holdings was 37.38. The lowest was 3.46. And the median was 12.26.

FRA:2M7C's EV-to-EBITDA is ranked better than
91.49% of 705 companies
in the Drug Manufacturers industry
Industry Median: 14.53 vs FRA:2M7C: 3.96

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-05), China Medical System Holdings's stock price is €0.83. China Medical System Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.126. Therefore, China Medical System Holdings's PE Ratio for today is 6.59.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


China Medical System Holdings EV-to-EBITDA Historical Data

The historical data trend for China Medical System Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Medical System Holdings EV-to-EBITDA Chart

China Medical System Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.88 5.27 6.36 5.71 8.33

China Medical System Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.36 - 5.71 - 8.33

Competitive Comparison of China Medical System Holdings's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, China Medical System Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Medical System Holdings's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Medical System Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where China Medical System Holdings's EV-to-EBITDA falls into.



China Medical System Holdings EV-to-EBITDA Calculation

China Medical System Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1521.192/376.066
=4.05

China Medical System Holdings's current Enterprise Value is €1,521 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Medical System Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €376 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Medical System Holdings  (FRA:2M7C) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

China Medical System Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.83/0.126
=6.59

China Medical System Holdings's share price for today is €0.83.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Medical System Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.126.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


China Medical System Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of China Medical System Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


China Medical System Holdings (FRA:2M7C) Business Description

Traded in Other Exchanges
Address
510 King’s Road, Unit 2106, 21st Floor, North Point, Island Place Tower, Hong Kong, HKG
China Medical System Holdings Ltd is active in the healthcare segment. It is one of the leading China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil; Salofalk; Combizym; Ganfule Capsules; Xidakang; Hirudoid; and others. Geographically, it derives revenue from China.

China Medical System Holdings (FRA:2M7C) Headlines

No Headlines